New insights in the treatment of nontuberculous mycobacterial pulmonary disease.

about

New insights in the treatment of nontuberculous mycobacterial pulmonary disease.

Item

http://www.wikidata.org/entity/Q47917686

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

New insights in the treatment of nontuberculous mycobacterial pulmonary disease.

@en

New insights in the treatment of nontuberculous mycobacterial pulmonary disease.

@nl

type

Item

label

New insights in the treatment of nontuberculous mycobacterial pulmonary disease.

@en

New insights in the treatment of nontuberculous mycobacterial pulmonary disease.

@nl

prefLabel

New insights in the treatment of nontuberculous mycobacterial pulmonary disease.

@en

New insights in the treatment of nontuberculous mycobacterial pulmonary disease.

@nl

P1476

New insights in the treatment of nontuberculous mycobacterial pulmonary disease.

@en

P2093

Mike Marvin Ruth

http://www.w3.org/2001/XMLSchema#string

P2860

Pulmonary Nontuberculous Mycobacterial Infection. A Multisystem, Multigenic Disease

Susceptibility of Mycobacterium abscessus to antimycobacterial drugs in preclinical models

The antibiotic resistance arrow of time: efflux pump induction is a general first step in the evolution of mycobacterial drug resistance

Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease.

Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.

Azithromycin Dose To Maximize Efficacy and Suppress Acquired Drug Resistance in Pulmonary Mycobacterium avium Disease

Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary Disease

Moxifloxacin's Limited Efficacy in the Hollow-Fiber Model of Mycobacterium abscessus Disease.

Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection.

ATP synthase inhibition of Mycobacterium avium is not bactericidal.

P304

1109-1112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.2217/FMB-2017-0144

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jakko van Ingen

P577

2017-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28972416

http://www.w3.org/2001/XMLSchema#string